CRISPR Therapeutics AG Executives Sell 18,910 Shares on March 23, 2026.

CRISPR Therapeutics AG, a biotechnology company, has recently disclosed that its General Counsel and Secretary, James R. Kasinger, has sold 3,182 shares at a price of $46.78 per share on March 23, 2026. Additionally, the company's Director and Chief Executive Officer, Samarth Kulkarni, has sold 10,020 shares at the same price point on the same date. Furthermore, the company's Chief Financial Officer, Raju Prasad, has sold 3,708 shares at $46.78 per share on March 23, 2026.